Professor Beate Kampmann
Staats Exam MD DTM&H PhD FRCPCH
Professor of Paediatric Infection & Immunity, Director of The Vaccine Centre
Professor Beate Kampmann joined the LSHTM from Imperial College London in May 2018. She trained as a clinician-scientist in Paediatric Infectious Diseases in Germany, UK, France, USA and South Africa. Beate holds a Chair in Paediatric Infection & Immunity and was appointed as the Scientific Director (Theme Leader) for Vaccinology research at the MRC Unit The Gambia in July 2010. She directs a comprehensive childhood infection research program both in the UK and sub-saharan Africa and will lead The Vaccine Centre @ LSHTM from August 2018.
As one of the three theme leaders at the MRC Unit in The Gambia, she oversees all research activities in infant immunology, childhood tuberculosis and molecular diagnostics, ranging from basic research into innate and acquired immune responses to infection and vaccination in pregnant women and infants to clinical trials of novel vaccines, adjuvants adn administration modalities.
Over the last few years she has conducted a number of studies in both UK and West Africa investigating the scientific and implementation challenges of maternal immunization.
She is the director of IMPRINT- the IMmunising PRegnant women and INfants network, one of the 5 MRC-funded networks for vaccines (www.imprint-network.co.uk).
Beate has a strong track record of developing the next generation of paediatric infectious diseases clinician scientists in the UK and Africa and has supervised a large group of PhD and MSc students in both locations. She was awarded the President's Medal for Excellence in research Supervision at Imperial College in 2015. She has acted as a mentor for many scientists and clinicians, in particular for women in science.
The aim of Beate's research is to link scientific discoveries in the laboratory to the delivery of evidence-based care for children in the UK and Africa.
She has conducted translational research in childhood tuberculosis for many years with a focus on correlates of protection, biomarkers for protection against disease progression and development and evaluation of novel diagnostics. She brought together investigators in Europe around childhood TB research by setting up the ptbnet- a network of clinicians and scientists aiming to improve the diagnosis, prevention and therapy of childhood TB.
Her vaccine-related work focuses on applying systems vaccinology tools to improve our insights into the development of the neonatal immune system, in the context of infections and vaccination.
She directs several projects exploring maternal immmunisation as a tool to decrease infant morbidity and mortality. This extends from the associated questions of transplacental antibody transfer, impact on developing neonatal immunity, role of co-infections and co-morbidities to the challenges of acceptancy and implementation of such an intervention.